Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max Nieuwdorp

Showing results (41-50 of 415) with videos related to

Pageof 42
Sort By:
Journal of Clinical Gastroenterology|October 9, 2015
Gut Microbiota and Energy Expenditure in Health and ObesityGuido J Bakker, Jing Zhao, Hilde Herrema, et al.
European Journal of Pharmacology|June 23, 2015
About the gut microbiome as a pharmacological target in atherosclerosisJulia J Witjes, Daniel H van Raalte, Max Nieuwdorp
Current Opinion in Gastroenterology|November 19, 2013
Fecal microbiota transplantation: facts and controversiesEls van Nood, Peter Speelman, Max Nieuwdorp, et al.
European Heart Journal|November 13, 2013
The gut microbiome as novel cardio-metabolic target: the time has come!Sarah Vinjé, Erik Stroes, Max Nieuwdorp, et al.
Gut Microbes|August 23, 2023
Targeting nonalcoholic fatty liver disease via gut microbiome-centered therapiesMijra Koning, Hilde Herrema, Max Nieuwdorp, et al.
Gut|February 1, 2018
Potential of butyrate to influence food intake in mice and menKristina S Fluitman, Madelief Wijdeveld, Max Nieuwdorp, et al.
Metabolites|September 23, 2022
Microbial Tryptophan Metabolism Tunes Host Immunity, Metabolism, and Extraintestinal DisordersMoyan Liu, Max Nieuwdorp, Willem M de Vos, et al.
Current Diabetes Reports|May 3, 2019
Epigenetic Markers and Microbiota/Metabolite-Induced Epigenetic Modifications in the Pathogenesis of Obesity, Metabolic Syndrome, Type 2 Diabetes, and Non-alcoholic Fatty Liver DiseaseDaniela Stols-Gonçalves, Luca Schiliró Tristão, Peter Henneman, et al.
Gastroenterology|February 12, 2020
Nonalcoholic Fatty Liver Disease: Modulating Gut Microbiota to Improve Severity?Judith Aron-Wisnewsky, Moritz V Warmbrunn, Max Nieuwdorp, et al.
Atherosclerosis|September 28, 2020
How strong is the evidence that gut microbiota composition can be influenced by lifestyle interventions in a cardio-protective way?Victor Gerdes, Miguel Gueimonde, Lotta Pajunen, et al.
Pageof 42

Showing results (41-50 of 415) with videos related to

Sort By:
Pageof 42
Journal of Clinical Gastroenterology|October 9, 2015
Gut Microbiota and Energy Expenditure in Health and ObesityGuido J Bakker, Jing Zhao, Hilde Herrema, et al.
European Journal of Pharmacology|June 23, 2015
About the gut microbiome as a pharmacological target in atherosclerosisJulia J Witjes, Daniel H van Raalte, Max Nieuwdorp
Current Opinion in Gastroenterology|November 19, 2013
Fecal microbiota transplantation: facts and controversiesEls van Nood, Peter Speelman, Max Nieuwdorp, et al.
European Heart Journal|November 13, 2013
The gut microbiome as novel cardio-metabolic target: the time has come!Sarah Vinjé, Erik Stroes, Max Nieuwdorp, et al.
Gut Microbes|August 23, 2023
Targeting nonalcoholic fatty liver disease via gut microbiome-centered therapiesMijra Koning, Hilde Herrema, Max Nieuwdorp, et al.
Gut|February 1, 2018
Potential of butyrate to influence food intake in mice and menKristina S Fluitman, Madelief Wijdeveld, Max Nieuwdorp, et al.
Metabolites|September 23, 2022
Microbial Tryptophan Metabolism Tunes Host Immunity, Metabolism, and Extraintestinal DisordersMoyan Liu, Max Nieuwdorp, Willem M de Vos, et al.
Current Diabetes Reports|May 3, 2019
Epigenetic Markers and Microbiota/Metabolite-Induced Epigenetic Modifications in the Pathogenesis of Obesity, Metabolic Syndrome, Type 2 Diabetes, and Non-alcoholic Fatty Liver DiseaseDaniela Stols-Gonçalves, Luca Schiliró Tristão, Peter Henneman, et al.
Gastroenterology|February 12, 2020
Nonalcoholic Fatty Liver Disease: Modulating Gut Microbiota to Improve Severity?Judith Aron-Wisnewsky, Moritz V Warmbrunn, Max Nieuwdorp, et al.
Atherosclerosis|September 28, 2020
How strong is the evidence that gut microbiota composition can be influenced by lifestyle interventions in a cardio-protective way?Victor Gerdes, Miguel Gueimonde, Lotta Pajunen, et al.
Pageof 42